Haemophilia is an inherited, rare bleeding disorder in which the blood fails to clot due to a lack or deficiency of clotting ...

The demand for treatments targeting myeloproliferative disorders is rising sharply, propelled by several key factors that underscore the market's rob ...

Be Biopharma, Inc. ("Be Bio" or "the Company"), a clinical-stage company pioneering the discovery and development of engineered B Cell Medicines (BCMs), today announced the first participant was ...

Jigar Kotecha, Secretary of the Hemophilia Society (Mumbai Chapter), said that a purchase order for 6,130 vials was issued on ...

New research from Stellenbosch University suggests a potential link between myalgic encephalomyelitis/chronic fatigue ...

Medically reviewed by David Ozeri, MD Acute (short-term) inflammation occurs when your immune system sends inflammatory cells ...

Deadly and silent, thrombosis affects thousands of Australian women each year during pregnancy, postpartum, menopause or ...

The Global Coagulation Factor Deficiency Market Report (2025-2035) highlights advances in treatment options for blood clotting disorders like Hemophilia A, Hemophilia B, and Von Willebrand Disease.

BBAI Factor-Based Stock Analysis July 23, 2025 — 10:04 am EDT Written by John Reese for Validea -> ...

The Reserve Bank of New Zealand (RBNZ) said on Monday its sectoral factor model of core inflation was 2.8% year-on-year in the second quarter, down from 2.9% in the prior quarter.

Billy Joel says he’s feeling “good” two months after he was diagnosed with a brain disorder. Joel, 76, gave an update on his condition — a disorder called normal pressure hydrocephalus, in ...

Studies suggest that as many as one in ten of us look to the growing army of chatbots powered by artificial intelligence, or ...